Showing results (2041-2050 of 14,098) with videos related to
Sort By:
Pageof 1,410
Gynecologic Oncology|April 6, 2020
A randomized phase II evaluation of weekly gemcitabine plus pazopanib versus weekly gemcitabine alone in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinomaL R Duska, G R Petroni, N Varhegyi, et al.Gynecologic Oncology|August 29, 2020
Investigation of clinicopathological features of vulvar cancer in 1068 patients: A Japanese Gynecologic Oncology Group (JGOG) nationwide survey studyShin Nishio, Kenta Murotani, Sari Nakao, et al.Gynecologic Oncology|August 31, 2020
The effect of age on efficacy, safety and patient-centered outcomes with rucaparib: A post hoc exploratory analysis of ARIEL3, a phase 3, randomized, maintenance study in patients with recurrent ovarian carcinomaNicoletta Colombo, Amit M Oza, Domenica Lorusso, et al.Gynecologic Oncology|March 31, 2020
Multivariable analysis of association of beta-blocker use and survival in advanced ovarian cancerR Gonzalez, A A Gockley, A Melamed, et al.Gynecologic Oncology|March 29, 2020
Risk factors associated with delayed discharge following robotic assisted surgery for gynecologic malignancyJoan R Tymon-Rosario, Devin T Miller, Akiva P Novetsky, et al.Gynecologic Oncology|April 1, 2020
Non-epithelial ovarian cancer in Denmark - Incidence and survival over nearly 40 yearsA K K Bennetsen, L Baandrup, G L Aalborg, et al.Gynecologic Oncology|October 31, 2019
Identification of a RNA-seq-based signature to improve prognostics for uterine sarcomaJian-Guo Zhou, He-Tong Zhao, Su-Han Jin, et al.Gynecologic Oncology|November 27, 2018
Adjuvant therapy in stage III endometrial cancer confined to the pelvisReem Albeesh, Guy-Anne Turgeon, Joanne Alfieri, et al.Gynecologic Oncology|December 1, 2018
Preoperatively predicting non-home discharge after surgery for gynecologic malignancyCourtney A Penn, Neil S Kamdar, Daniel M Morgan, et al.Gynecologic Oncology|September 7, 2005
Participant recruitment and motivation for participation in optical technology for cervical cancer screening research trialsOlga M Shuhatovich, Mathilde P Sharman, Yvette N Mirabal, et al.Pageof 1,410